- Home
- FBRX vs LRFC Comparison
FBRX vs LRFC Comparison
Compare FBRX & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- LRFC
- Stock Information
- Founded
- FBRX N/A
- LRFC 2013
- Country
- FBRX United States
- LRFC United States
- Employees
- FBRX N/A
- LRFC N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- LRFC Finance: Consumer Services
- Sector
- FBRX Health Care
- LRFC Finance
- Exchange
- FBRX Nasdaq
- LRFC Nasdaq
- Market Cap
- FBRX 76.1M
- LRFC 66.5M
- IPO Year
- FBRX N/A
- LRFC 2013
- Fundamental
- Price
- FBRX $10.98
- LRFC $24.78
- Analyst Decision
- FBRX Strong Buy
- LRFC
- Analyst Count
- FBRX 4
- LRFC 0
- Target Price
- FBRX $77.58
- LRFC N/A
- AVG Volume (30 Days)
- FBRX 27.5K
- LRFC 9.8K
- Earning Date
- FBRX 03-17-2025
- LRFC 03-13-2025
- Dividend Yield
- FBRX N/A
- LRFC 5.41%
- EPS Growth
- FBRX N/A
- LRFC N/A
- EPS
- FBRX N/A
- LRFC N/A
- Revenue
- FBRX N/A
- LRFC $19,936,000.00
- Revenue This Year
- FBRX N/A
- LRFC $3.63
- Revenue Next Year
- FBRX N/A
- LRFC N/A
- P/E Ratio
- FBRX N/A
- LRFC N/A
- Revenue Growth
- FBRX N/A
- LRFC N/A
- 52 Week Low
- FBRX $4.11
- LRFC $20.65
- 52 Week High
- FBRX $28.68
- LRFC $26.00
- Technical
- Relative Strength Index (RSI)
- FBRX 36.53
- LRFC 52.18
- Support Level
- FBRX $9.81
- LRFC $24.22
- Resistance Level
- FBRX $13.13
- LRFC $25.00
- Average True Range (ATR)
- FBRX 1.52
- LRFC 0.34
- MACD
- FBRX -0.08
- LRFC 0.01
- Stochastic Oscillator
- FBRX 18.17
- LRFC 71.79
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.